MedTrace Logo

Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research

NCT02707653 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-06-12

No results posted yet for this study

Summary

This study will investigate the use of misoprostol for first-line treatment of incomplete abortion at tertiary hospitals in Myanmar.

Conditions

  • Incomplete Abortion

Interventions

DRUG

Misoprostol

400 mcg sublingual misoprostol

Sponsors & Collaborators

  • Department of Medical Research, Lower Myanmar

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Burma

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02707653 on ClinicalTrials.gov